The thiazolidinedione insulin sensitiser, BRL 49653, increases the expression of PPAR-gamma and aP(2) in adipose tissue of high-fat-fed rats

被引:69
作者
Pearson, SL [1 ]
Cawthorne, MA [1 ]
Clapham, JC [1 ]
Dunmore, SJ [1 ]
Holmes, SD [1 ]
Moore, GBT [1 ]
Smith, SA [1 ]
Tadayyon, M [1 ]
机构
[1] SMITHKLINE BEECHAM PHARMACEUT,WELWYN GARDEN CIT AL6 9AR,HERTS,ENGLAND
关键词
D O I
10.1006/bbrc.1996.1876
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of the thiazolidinedione insulin sensitiser BRL 49653 on plasma leptin concentrations and on epididymal fat OB, PPAR-gamma and aP(2) mRNA expression were examined in high-fat-fed and high-carbohydrate-fed adult Wistar rats. Diets were given for 4 weeks, with BRL 49653 (10 mu mol/kg/day) administered by oral gavage for the last 4 days. Treatment with BRL 49653 reduced plasma leptin concentrations in high-fat-fed rats from 2.34 +/- 0.19 (n=9) to 1.42 +/- 0.09 (n=9) ng/ml (p<0.001). Plasma leptin was unaffected by BRL 49653 in the high-carbohydrate-fed rats. There was no difference in OB mRNA expression between high-fat-fed and high-carbohydrate-fed rats, with or without treatment. PPAR-gamma and aP(2) mRNA expression were significantly increased in the high-fat-fed rats treated with BRL 49653 (p<0.01 and p<0.001 respectively), but not in carbohydrate-fed rats. (C) 1996 Academic Press
引用
收藏
页码:752 / 757
页数:6
相关论文
共 23 条
[1]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[2]   THE OB GENE AND INSULIN - A RELATIONSHIP LEADING TO CLUES TO THE UNDERSTANDING OF OBESITY [J].
CUSIN, I ;
SAINSBURY, A ;
DOYLE, P ;
ROHNERJEANRENAUD, F ;
JEANRENAUD, B .
DIABETES, 1995, 44 (12) :1467-1470
[3]   PATHOGENESIS OF NIDDM - A BALANCED OVERVIEW [J].
DEFRONZO, RA ;
BONADONNA, RC ;
FERRANNINI, E .
DIABETES CARE, 1992, 15 (03) :318-368
[4]   LEPTIN LEVELS REFLECT BODY LIPID-CONTENT IN MICE - EVIDENCE FOR DIET-INDUCED RESISTANCE TO LEPTIN ACTION [J].
FREDERICH, RC ;
HAMANN, A ;
ANDERSON, S ;
LOLLMANN, B ;
LOWELL, BB ;
FLIER, JS .
NATURE MEDICINE, 1995, 1 (12) :1311-1314
[5]   CHARACTERIZATION OF NEW ORAL ANTIDIABETIC AGENT CS-045 - STUDIES IN KK AND OB OB MICE AND ZUCKER FATTY RATS [J].
FUJIWARA, T ;
YOSHIOKA, S ;
YOSHIOKA, T ;
USHIYAMA, I ;
HORIKOSHI, H .
DIABETES, 1988, 37 (11) :1549-1558
[6]   WEIGHT-REDUCING EFFECTS OF THE PLASMA-PROTEIN ENCODED BY THE OBESE GENE [J].
HALAAS, JL ;
GAJIWALA, KS ;
MAFFEI, M ;
COHEN, SL ;
CHAIT, BT ;
RABINOWITZ, D ;
LALLONE, RL ;
BURLEY, SK ;
FRIEDMAN, JM .
SCIENCE, 1995, 269 (5223) :543-546
[7]  
IBRAHIMI A, 1994, MOL PHARMACOL, V46, P1070
[8]   EFFECT OF NEW ORAL ANTIDIABETIC AGENT CS-045 ON GLUCOSE-TOLERANCE AND INSULIN-SECRETION IN PATIENTS WITH NIDDM [J].
IWAMOTO, Y ;
KUZUYA, T ;
MATSUDA, A ;
AWATA, T ;
KUMAKURA, S ;
INOOKA, G ;
SHIRAISHI, I .
DIABETES CARE, 1991, 14 (11) :1083-1086
[9]   CONTROL OF LIPOGENESIS BY DIETARY LINOLEIC-ACID AND ITS INFLUENCE ON THE DEPOSITION OF FAT [J].
JEFFCOAT, R ;
ROBERTS, PA ;
JAMES, AT .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1979, 101 (02) :447-453
[10]   SUPPRESSION OF GLUT4 EXPRESSION IN SKELETAL-MUSCLE OF RATS THAT ARE OBESE FROM HIGH-FAT FEEDING BUT NOT FROM HIGH-CARBOHYDRATE FEEDING OR GENETIC OBESITY [J].
KAHN, BB ;
PEDERSEN, O .
ENDOCRINOLOGY, 1993, 132 (01) :13-22